dc.creator | Reyes M. | |
dc.creator | Ramírez C. | |
dc.creator | Ñancucheo I. | |
dc.creator | Villegas R. | |
dc.creator | Schaffeld G. | |
dc.creator | Kriman L. | |
dc.creator | Gonzalez J. | |
dc.creator | Oyarzun P. | |
dc.date.accessioned | 2020-09-02T22:26:58Z | |
dc.date.accessioned | 2022-11-08T20:28:33Z | |
dc.date.available | 2020-09-02T22:26:58Z | |
dc.date.available | 2022-11-08T20:28:33Z | |
dc.date.created | 2020-09-02T22:26:58Z | |
dc.date.issued | 2017 | |
dc.identifier | 35, 4, 626-632 | |
dc.identifier | 0264410X | |
dc.identifier | https://hdl.handle.net/20.500.12728/6005 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146864 | |
dc.language | en | |
dc.publisher | Elsevier Ltd | |
dc.subject | Atlantic salmon | |
dc.subject | DNA vaccine | |
dc.subject | DOTAP | |
dc.subject | Feed | |
dc.subject | IPNV | |
dc.subject | Liposome | |
dc.subject | Oral delivery | |
dc.subject | Salmon salar | |
dc.subject | 1,2 dioleoyl 3 trimethylammoniopropane | |
dc.subject | DNA vaccine | |
dc.subject | infectious pancreatic necrosis virus vaccine | |
dc.subject | protein VP2 | |
dc.subject | unclassified drug | |
dc.subject | virus vaccine | |
dc.subject | DNA vaccine | |
dc.subject | drug carrier | |
dc.subject | immunological adjuvant | |
dc.subject | liposome | |
dc.subject | virus antibody | |
dc.subject | animal food | |
dc.subject | animal tissue | |
dc.subject | antibody detection | |
dc.subject | aquaculture | |
dc.subject | Article | |
dc.subject | controlled study | |
dc.subject | DNA immunization | |
dc.subject | drug safety | |
dc.subject | histology | |
dc.subject | in vivo study | |
dc.subject | infectious pancreatic necrosis | |
dc.subject | infectious pancreatic necrosis virus | |
dc.subject | liposomal delivery | |
dc.subject | liver | |
dc.subject | mortality | |
dc.subject | nonhuman | |
dc.subject | pancreas | |
dc.subject | particle size | |
dc.subject | priority journal | |
dc.subject | provocation test | |
dc.subject | Salmo salar | |
dc.subject | animal | |
dc.subject | animal structures | |
dc.subject | birnavirus infection | |
dc.subject | blood | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | fish disease | |
dc.subject | immunology | |
dc.subject | infectious pancreatic necrosis virus | |
dc.subject | oral drug administration | |
dc.subject | pathology | |
dc.subject | survival analysis | |
dc.subject | treatment outcome | |
dc.subject | veterinary | |
dc.subject | Adjuvants, Immunologic | |
dc.subject | Administration, Oral | |
dc.subject | Animal Structures | |
dc.subject | Animals | |
dc.subject | Antibodies, Viral | |
dc.subject | Birnaviridae Infections | |
dc.subject | Drug Carriers | |
dc.subject | Enzyme-Linked Immunosorbent Assay | |
dc.subject | Fish Diseases | |
dc.subject | Infectious pancreatic necrosis virus | |
dc.subject | Liposomes | |
dc.subject | Salmo salar | |
dc.subject | Survival Analysis | |
dc.subject | Treatment Outcome | |
dc.subject | Vaccines, DNA | |
dc.title | A novel “in-feed” delivery platform applied for oral DNA vaccination against IPNV enables high protection in Atlantic salmon (Salmon salar) | |
dc.type | Article | |